lobbying_activities: 1839031

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1839031	abfabd21-9ced-4068-80e5-82552ac39d8f	Q2	ROBERT ARMITAGE	401103512	ELI LILLY AND COMPANY	2016	second_quarter	CPT	Biopharmaceutical-related IP protection issues, including those associated with the MODDERN Cures Act (H.R. 3116, 113th Cong.),Dormant Therapies Act (S. 3004, 113th Cong.), the Innovation Act (H.R. 9, 114th Cong.) and the PATENT Act (S. 1137, 114th Cong.).	HOUSE OF REPRESENTATIVES,SENATE	8160		0	0	2016-07-11T09:37:09.647000-04:00